FindTrial
Sign In

Effect of Amalaki Beej Churna on Shweta Pradar

Effect of Amalaki Beej Churna (Embellica officinalis Gaertn.) on Shweta Pradar (Leucorrhoea)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031391
Enrollment
60
Registered
2021-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N739- Female pelvic inflammatory disease, unspecified

Interventions

Intervention1: Amalaki beej churna in shweta pradar dose-3 gm BD for 1 month: DOSE -3gm twice a day with madhu with follow up upto 30,60,90 days Control Intervention1: compared with antibiotic named

Sponsors

Uma Singh Sachan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: females having white vaginal discharge

Exclusion criteria

Exclusion criteria: females having tuboovarian mass, leucorrhoea in pregnant women

Design outcomes

Primary

MeasureTime frame
associated symptoms as backache,pain in abdomen,frigidity,itching in genitilia,burning micturition,bodyache,headache,constipation,dyspareunia are noticed.Timepoint: at 4 weeks,8 weeks, 12 weeks—

Secondary

MeasureTime frame
Heaviness in body, burning feet syndrome,constipation are studiedTimepoint: At duration of 30 days, 60 days, 90 days.—

Countries

India

Contacts

Public ContactAnil Kumar Singh

Banaras Hindu University

anilkumar.singh113@gmail.com8874600002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026